Browsing Tag
Black Diamond Therapeutics
2 posts
Black Diamond Therapeutics reports strong early Phase 2 response for silevertinib in first-line NSCLC patients
Discover how Black Diamond Therapeutics’ silevertinib achieved a 60% response in first-line lung cancer and why its upcoming glioblastoma trial could reshape targeted oncology.
Precision oncology company Black Diamond Therapeutics raises $85m
Black Diamond Therapeutics, a precision oncology company based in Cambridge, has raised $85 million from a Series C…